Welcome to our dedicated page for Dlh Holdings news (Ticker: DLHC), a resource for investors and traders seeking the latest updates and insights on Dlh Holdings stock.
DLH Holdings Corp. (NASDAQ: DLHC) regularly issues news and updates related to its work in digital transformation and cyber security, systems engineering and integration, and science research and development for federal and government-related customers. Company press releases cover financial results, contract awards, technology milestones, and regulatory disclosures that reflect its role in technology, public health, and cyber readiness missions.
Investors following DLHC news will find quarterly and annual earnings announcements, along with management commentary on revenue trends, contract backlog, debt reduction, and cash flow. These releases often discuss how federal budget priorities, small business set-aside policies, and procurement dynamics affect DLH’s contract portfolio, including programs in areas such as pharmacy and logistics services and monitoring and compliance work for federal agencies.
DLH also publishes news on significant contract wins and extensions, such as multi-year task orders to provide information technology services, enterprise IT systems management, cyber security, software development, cloud computing, and advanced engineering support for organizations like the National Institutes of Health’s Office of Information Technology and the Telemedicine and Advanced Technology Research Center. These announcements highlight the company’s involvement in AI, machine learning, modeling and simulation, robotic process automation, and cloud-enabled big data analytics for military and health missions.
In addition, DLH issues updates on technology and cyber milestones, including achieving Cybersecurity Maturity Model Certification (CMMC) Level 2 and recognition for projects that integrate virtual reality, digital twins, AI, robotics, and automated data collection in military health settings. For anyone tracking DLHC, this news feed provides ongoing insight into the company’s contract activity, mission areas, and reported financial performance.
DLH Holdings Corp. (NASDAQ: DLHC) announced a follow-on contract with the Department of Veterans Affairs worth $202 million to provide medical logistics for the Consolidated Mail Outpatient Pharmacy. This contract spans one year with four optional extensions. It highlights DLH's strong 20-year partnership with the VA and the importance of mail order in veteran care, especially during the COVID-19 pandemic. Last year, the CMOP program processed over 120 million prescriptions nationwide, showcasing DLH's role in improving pharmaceutical delivery to veterans.
DLH Holdings Corp. (NASDAQ: DLHC) will announce its financial results for the fiscal second quarter ending March 31, 2021, on May 5, 2021, after market close. A conference call for investors will be held on May 6, 2021, at 11:00 a.m. ET, where management will discuss the results and operational performance. Interested parties can access the call via phone or through the Investor Relations section of the DLH website, where presentation materials will also be available. DLH specializes in healthcare and human services for federal agencies, employing over 2,200 staff.
DLH Holdings Corp. (NASDAQ: DLHC) will release its fiscal first quarter financial results for the period ending December 31, 2020, on February 2, 2021, after market close. A conference call for investors is scheduled for February 3, 2021, at 11:00 a.m. Eastern Time, featuring senior management discussing financial results and operating trends, followed by a Q&A session. Interested parties can participate by calling 888-347-5290 or 412-317-5256. For more information about DLH’s services and operations, visit www.dlhcorp.com.
DLH Holdings Corp. (NASDAQ: DLHC) has secured a contract valued at up to $42 million to continue operating the AIDS Clinical Trials Group's (ACTG) Network Coordinating Center (NCC), funded by the National Institutes of Health. This contract spans one base year and six option years. DLH, managing the NCC since 1987, provides essential support for HIV research and clinical trials, bolstering public health initiatives. The ACTG network, active in 15 countries, is pivotal in HIV treatment improvements and has recently expanded its research to include studies for COVID-19.
DLH Holdings Corp. (NASDAQ: DLHC) announced its participation in two virtual investor events in Q1 2021. The company will attend the Noble Capital Markets’ 17th Annual Small & Microcap Investor Conference on January 20, and the Alliance Global Partners’ Emerging Growth Technology Conference on February 4. DLH is a leading provider of healthcare services to federal agencies, focusing on technology-enabled health services for military and veterans. Additional details, including presentation materials and opportunities for one-on-one meetings, will be available on the company’s website.
DLH Holdings Corp. (NASDAQ: DLHC) reported fiscal 2020 annual revenue of $209.2 million, up from $160.4 million in 2019, driven by new awards and acquisitions despite COVID-19 impacts. Earnings increased to $0.54 per diluted share from $0.41. Cash flow from operations reached $19.5 million, with a significant debt reduction of $19 million. The acquisition of Irving Burton Associates (IBA) for $32 million added over $140 million to the company’s backlog of $688.4 million.
DLH Holdings Corp. (NASDAQ: DLHC) will announce its financial results for the fiscal fourth quarter ended September 30, 2020, on December 7, 2020, before market opening. The Company will conduct a conference call on the same day at 11:00 a.m. ET, where senior management will discuss financial results and operating trends. Interested listeners can join by dialing 888-347-5290 or 412-317-5256. A replay will be available two hours post-call. DLH specializes in providing healthcare and human services to federal agencies, employing over 2,200 staff nationwide.
DLH Holdings Corp. (NASDAQ: DLHC) will participate in the Truist Virtual Industrials & Services Summit on December 8, 2020. The event will feature one-on-one calls with management, providing opportunities for institutional investors to engage directly with the Company. A presentation will also be accessible on the Company's website.
DLH specializes in innovative healthcare services for federal agencies, focusing on technology-enabled solutions across various health and human services programs, employing approximately 2,000 staff nationwide.
DLH Holdings Corp. (NASDAQ: DLHC) announced the appointment of Sandra Halverson, MPH, PhD, as Chief Scientist effective November 1, 2020. Dr. Halverson, previously Director of the Survey Operations Center, will work with the Executive Leadership Team to shape research priorities and represent the company publicly within the health and life sciences sectors. Her background includes a PhD in Epidemiology and experience as Project Director for the NIEHS Sister Study. The leadership believes her skills will enhance DLH's competitive position amid current public health challenges.
DLH Holdings Corp. (NASDAQ: DLHC) has been awarded a significant contract renewal with the Administration for Children and Families' Office of Head Start, valued at $150 million over eight months and four one-year options. This renewal enhances monitoring support services using advanced technology and data analytics. DLH emphasizes its commitment to quality improvement, particularly in education and family support during COVID-19 challenges. The company will evaluate over 2,000 grantees across the U.S., continuing its long-standing partnership with ACF.